Cancer is among the underlying conditions that increase risk for COVID-19.
22% of patients critically ill; older age, chronic cardiac disease linked to higher in-hospital mortality.
Cryptogenic strokes more common, mortality higher in COVID-19 patients than in controls with stroke.
New findings suggest that the HSD3B1 genotype can be used to risk stratify white men with low-volume metastatic prostate cancer.
About 45 weeks needed to clear surgery backlog if countries up surgical volume by 20% later.
Previous retrospective studies have suggested that 5-alpha-reductase inhibitors may beneficial effects on bladder cancer development and/or recurrence, but a prospective cohort study found no protective effect.
In a study, researchers identified 7 chemicals associated with an increased risk for chronic kidney disease.
Rates of regional- and distant-stage prostate cancer increasing in the US among men older than 50 years.
Height inversely linked to bladder cancer, while excess BMI gain in childhood linked to increased risk.
Insulin usage linked to poor prognosis; ACEI/ARB use did not impact clinical outcome in those with hypertension.